EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Management challenges of active tuberculosis complicated by thrombocytosis and squamous cell lung carcinoma

Chen Zhu, Yanli Xu, XiaoYing Li, HongBao Ma, Tingshu Jiang

Frontiers in Oncology · 10.03.2026 · 16

DOI: 10.3389/fonc.2026.1723876 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 10.03.2026. Verfasst von Chen Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Yantai Yuhuangding Hospital, Shandong, Yantai, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This report assesses the feasibility of a sequential treatment strategy for a patient with active tuberculosis (TB) complicated by thrombocytosis and squamous cell lung carcinoma, involving initial anti-TB therapy combined with aspirin, followed by anticancer treatment. It highlights the challenge of balancing infection control, hematologic stability, and oncologic management in this complex scenario. Case presentation A 55-year-old man with a 15-day history of cough, sputum, and fever was found to have markedly elevated platelet levels. Bronchoscopy confirmed active TB with concurrent lung cancer. Following anti-TB therapy combined with aspirin for antiplatelet management, platelet counts returned to normal. One month later, antitumor chemotherapy with nab-paclitaxel and carboplatin was initiated, leading to effective disease control.

Conclusion

Active TB complicated by thrombocytosis and squamous cell lung carcinoma poses diagnostic and therapeutic challenges. This case demonstrates that early anti-TB therapy combined with aspirin can effectively normalize platelet counts and facilitate the timely initiation of anticancer treatment.

Schlagwörter

Stichwörter der Autor:innen

active tuberculosisanti-tuberculosis therapyanti-tumor treatmentsquamous cell lung carcinomathrombocytosis

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Yantai Yuhuangding Hospital, Shandong, Yantai, China.
  • Department of Infectious Diseases, Yantai Qishan Hospital, Shandong, Yantai, China.
  • Department of Medical Affairs, Yantai Qishan Hospital, Shandong, Yantai, China.
  • Department of Tuberculosis, Yantai Qishan Hospital, Shandong, Yantai, China.

Zitieren

APA

Zhu, C., Xu, Y., Li, X., Ma, H., & Jiang, T. (2026). Case Report: Management challenges of active tuberculosis complicated by thrombocytosis and squamous cell lung carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1723876

Vancouver

Zhu C, Xu Y, Li X, Ma H, Jiang T. Case Report: Management challenges of active tuberculosis complicated by thrombocytosis and squamous cell lung carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1723876

BibTeX
@article{Zhu2026,
  author = {Zhu, Chen and Xu, Yanli and Li, XiaoYing and Ma, HongBao and Jiang, Tingshu},
  title = {Case Report: Management challenges of active tuberculosis complicated by thrombocytosis and squamous cell lung carcinoma},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1723876}
}
Kostenlos starten →